HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg

Published:2016-05-03 Issue:3 Volume:25 Page:131-132
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

Kjeldsen Sverre E.¹,Hedner Thomas²,Narkiewicz Krzysztof³

Affiliation:

1. Department of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway;

2. Department of Medicine, University of Göteborg, Sahlgrenska Academy, Göteborg, Sweden;

3. Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/08037051.2016.1182857

Reference9 articles.

1. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

2. A Randomized Trial of Intensive versus Standard Blood-Pressure Control

3. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

4. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses

5. The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study;Blood Pressure;2018-09-03

2. Who might benefit from Systolic Blood Pressure Intervention Trial's lower blood pressure targets? LIFE in the fast lane;Journal of Hypertension;2018-04

3. Vital Signs;The Physical Exam;2017-11-09

4. Hypertension in the elderly: Change of, or new implications within the existing, paradigm?;European Geriatric Medicine;2017-09

5. Target Blood Pressure for Treatment;Hypertension;2016-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3